LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 78 filers reported holding LEGEND BIOTECH CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118,521,196 | -11.6% | 1,764,496 | -9.1% | 0.32% | -5.1% |
Q2 2023 | $134,022,849 | +18.8% | 1,941,516 | -17.0% | 0.33% | +17.3% |
Q1 2023 | $112,776,936 | -3.4% | 2,338,800 | 0.0% | 0.28% | -12.1% |
Q4 2022 | $116,752,896 | +22.4% | 2,338,800 | 0.0% | 0.32% | +15.4% |
Q3 2022 | $95,423,000 | -17.9% | 2,338,800 | +10.6% | 0.28% | -11.4% |
Q2 2022 | $116,259,000 | +51.4% | 2,113,800 | +0.0% | 0.32% | +82.7% |
Q1 2022 | $76,783,000 | -18.4% | 2,112,895 | +4.7% | 0.17% | -1.1% |
Q4 2021 | $94,051,000 | +5.2% | 2,017,835 | +14.1% | 0.18% | +2.9% |
Q3 2021 | $89,382,000 | +8.2% | 1,767,835 | -12.2% | 0.17% | +10.4% |
Q2 2021 | $82,643,000 | +35.2% | 2,013,239 | -4.4% | 0.15% | +30.5% |
Q1 2021 | $61,104,000 | +17.2% | 2,105,578 | +13.7% | 0.12% | +10.3% |
Q4 2020 | $52,141,000 | +58.1% | 1,851,600 | +73.3% | 0.11% | +39.0% |
Q3 2020 | $32,976,000 | +372.8% | 1,068,217 | +551.9% | 0.08% | +352.9% |
Q2 2020 | $6,974,000 | – | 163,872 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |